A detailed history of Renaissance Group LLC transactions in Danaher Corp stock. As of the latest transaction made, Renaissance Group LLC holds 126,429 shares of DHR stock, worth $30.7 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
126,429
Previous 128,646 1.72%
Holding current value
$30.7 Million
Previous $32.1 Million 1.67%
% of portfolio
1.26%
Previous 1.25%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $522,125 - $594,111
-2,217 Reduced 1.72%
126,429 $31.6 Million
Q1 2024

Apr 26, 2024

BUY
$224.58 - $256.19 $872,493 - $995,298
3,885 Added 3.11%
128,646 $32.1 Million
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $1.74 Million - $2.19 Million
9,392 Added 8.14%
124,761 $28.9 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $1.67 Million - $1.9 Million
7,155 Added 6.61%
115,369 $28.6 Million
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $4.2 Million - $4.78 Million
18,650 Added 20.82%
108,214 $26 Million
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $37,401 - $43,212
156 Added 0.17%
89,564 $22.6 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $1.28 Million - $1.5 Million
-5,305 Reduced 5.6%
89,408 $23.7 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $1.25 Million - $7.61 Million
5,051 Added 5.63%
94,713 $24.5 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $922,832 - $1.17 Million
3,892 Added 4.54%
89,662 $22.7 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $2.15 Million - $2.64 Million
-8,369 Reduced 8.89%
85,770 $25.2 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $27.5 Million - $31 Million
94,139 New
94,139 $31 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Renaissance Group LLC Portfolio

Follow Renaissance Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.